PA
IDYA icon

Perceptive Advisors’s IDEAYA Biosciences IDYA Stock Holding History

Perceptive Advisors’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,141,484
Closed -$4.7M – 131
2020
Q1 		$4.7M Hold
1,141,484
– – 0.12% 81
2019
Q4 		$8.56M Hold
1,141,484
– – 0.17% 71
2019
Q3 		$9.58M Hold
1,141,484
– – 0.26% 57
2019
Q2 		$11.4M Buy
+1,141,484
New +$12.4M 0.26% 60

Other funds holding IDYA

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Perceptive Advisors's IDYA Position: Q2 2020 in Review

Perceptive Advisors sold out of IDEAYA Biosciences (IDYA) in Q2 2020, closing a stake of 1,141,484 shares — an estimated $4.7M sold.

Perceptive Advisors first reported a position in IDYA in Q2 2019 and held it in 4 quarters. The position peaked at $11.4M in Q2 2019. 64 funds tracked by Wall St. Rank hold IDYA as of Q2 2020.

  • Perceptive Advisors reported no remaining IDEAYA Biosciences position as of Q2 2020 after selling out during the quarter.
  • Perceptive Advisors sold 1,141,484 IDEAYA Biosciences shares in Q2 2020, an estimated $4.7M.
  • Perceptive Advisors first reported a position in IDEAYA Biosciences in Q2 2019 and held it in 4 quarters.
  • Perceptive Advisors's IDEAYA Biosciences position peaked at $11.4M in Q2 2019.
  • 64 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2020.

Based on Perceptive Advisors's 13F filing for Q2 2020, filed 14 Aug 2020.